0

523620

PHRMASI

img img img img
No Data Available

PHAARMASIA LTD. Share Price Update

As of the latest trading session, PHAARMASIA LTD. is trading at ₹81.5, up by ₹0.66 or 0.81% from its previous close. The stock has moved between ₹81.50 and ₹81.65 today. Over the past year, the stock has delivered a return of 174.03%. In the last month, it has returned -25.83%.

Investment Returns

Over 1 Month -25.83% Over 3 Months -16.57% Over 6 Months 56.87% Over 1 Year 174.03%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

PHAARMASIA LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 55.70
  • P/E Ratio (TTM) 3.11
  • Beta 0.46
  • Book Value / share 9.52
  • Return on equity 0.00%
  • EPS (TTM) 3.36
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 16.27
info icon alternate text

PHAARMASIA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 16.05
Operating Expense 15.29
Net Profit 16.27
Net Profit Margin (%) 101.37
Earnings Per Share (EPS) 23.84
EBITDA 20.00
Effective Tax Rate (%) 18.27
Particulars SEP 2025 (Values in Cr)
Revenue 16.55
Operating Expense 14.99
Net Profit 1.74
Net Profit Margin (%) 10.51
Earnings Per Share (EPS) 2.54
EBITDA 1.75
Effective Tax Rate (%) -2.35
Particulars JUN 2025 (Values in Cr)
Revenue 6.87
Operating Expense 6.88
Net Profit 0.27
Net Profit Margin (%) 3.93
Earnings Per Share (EPS) 0.40
EBITDA 0.39
Effective Tax Rate (%) 12.90
Particulars MAR 2025 (Values in Cr)
Revenue 5.43
Operating Expense 6.13
Net Profit -0.53
Net Profit Margin (%) -9.76
Earnings Per Share (EPS) -0.77
EBITDA -0.43
Effective Tax Rate (%) -1.96
Particulars DEC 2024 (Values in Cr)
Revenue 4.72
Operating Expense 5.60
Net Profit -0.70
Net Profit Margin (%) -14.83
Earnings Per Share (EPS) -1.02
EBITDA -0.60
Effective Tax Rate (%) -1.44
Particulars MAR 2025 (Values in Cr)
Revenue 24.37
Operating Expense 26.72
Net Profit -1.59
Net Profit Margin (%) -6.52
Earnings Per Share (EPS) -2.33
EBITDA -1.26
Effective Tax Rate (%) 0.62
Particulars MAR 2024 (Values in Cr)
Revenue 30.59
Operating Expense 31.80
Net Profit -0.52
Net Profit Margin (%) -1.69
Earnings Per Share (EPS) -0.76
EBITDA -0.16
Effective Tax Rate (%) 5.45
Particulars MAR 2023 (Values in Cr)
Revenue 27.49
Operating Expense 29.43
Net Profit -1.26
Net Profit Margin (%) -4.58
Earnings Per Share (EPS) -1.84
EBITDA -1.02
Effective Tax Rate (%) 11.88
Particulars MAR 2022 (Values in Cr)
Revenue 17.22
Operating Expense 19.24
Net Profit -1.55
Net Profit Margin (%) -9.00
Earnings Per Share (EPS) -2.27
EBITDA -1.27
Effective Tax Rate (%) 1.28
Particulars MAR 2021 (Values in Cr)
Revenue 19.90
Operating Expense 20.31
Net Profit 0.31
Net Profit Margin (%) 1.55
Earnings Per Share (EPS) 0.46
EBITDA 0.83
Effective Tax Rate (%) 35.41
Particulars MAR 2025 (Values in Cr)
Book Value / Share 6.58
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -5.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.03
EBITDA Margin -0.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.62
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin -3.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.45
ROE % -17.98
ROCE % -17.75
Total Debt to Total Equity 0.00
EBITDA Margin -7.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.79
ROE % 3.34
ROCE % 5.02
Total Debt to Total Equity 0.01
EBITDA Margin 5.10
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 21.56
Total Liabilities 21.56
Total Equity 8.73
Share Outstanding 0
Price to Book Ratio 4.45
Return on Assets (%) -7.37
Return on Capital (%) -18.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.63
Total Assets 31.44
Total Liabilities 31.44
Total Equity 10.29
Share Outstanding 0
Price to Book Ratio 3.28
Return on Assets (%) -1.64
Return on Capital (%) -5.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 28.42
Total Liabilities 28.42
Total Equity 10.80
Share Outstanding 0
Price to Book Ratio 2.43
Return on Assets (%) -4.43
Return on Capital (%) -11.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 21.20
Total Liabilities 21.20
Total Equity 12.05
Share Outstanding 0
Price to Book Ratio 2.70
Return on Assets (%) -7.29
Return on Capital (%) -12.8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 21.91
Total Liabilities 21.91
Total Equity 13.65
Share Outstanding 0
Price to Book Ratio 1.80
Return on Assets (%) 1.42
Return on Capital (%) 2.28
Particulars MAR 2025 (Values in Cr)
Net Income -1.60
Cash from Operations 0.00
Cash from Investing -0.12
Cash from Financing -0.14
Net change in Cash -0.26
Free Cash Flow 0.16
Particulars MAR 2024 (Values in Cr)
Net Income -0.54
Cash from Operations 0.10
Cash from Investing 0.00
Cash from Financing -0.16
Net change in Cash -0.05
Free Cash Flow 0.13
Particulars MAR 2023 (Values in Cr)
Net Income -1.43
Cash from Operations 0.64
Cash from Investing -0.01
Cash from Financing -0.16
Net change in Cash 0.47
Free Cash Flow 0.67
Particulars MAR 2022 (Values in Cr)
Net Income -1.56
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.16
Free Cash Flow 0.00
Particulars MAR 2021 (Values in Cr)
Net Income 0.47
Cash from Operations 0.49
Cash from Investing 0.00
Cash from Financing -0.02
Net change in Cash 0.22
Free Cash Flow 0.49
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.07 13.67 1.60 253.43 23.12 40.00
BLISS GVS PHARMA LTD. 300.20 24.29 2.66 3175.78 118.35 304.30
CIPLA LTD 1398.95 27.70 3.28 113007.26 1165.55 1672.20
FERMENTA BIOTECH LIMITED 302.65 10.07 2.27 890.73 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2309.80 38.33 17.25 39129.41 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.07 23.13 4.26 253.43 23.12 40.00
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA IND LT 8604.25 103.40 26.92 21510.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 300.20 32.28 2.74 3175.78 118.35 304.30

PHAARMASIA LTD. shareholding pattern

Holding
26.42%
73.51%
0.05%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

PHAARMASIA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
81.50 0.81 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 83.00
  • 26 Days 91.20
  • 10 Days 86.50
  • 50 Days 92.50
  • 12 Days 87.60
  • 100 Days 88.30
  • 20 Days 90.20
  • 200 Days 76.00
79.85 PIVOT
First Support 78.19 First Resistance 82.49 Second Support 75.55 Second Resistance 84.15 Third Support 73.89 Third Resistance 86.79
RSI 32.55 ADX 32.24 MACD -3.12 Williams % R -85.92 Commodity Channel Index (CCI) -155.60
Date 2026-05-22 Week 163.00 Same Day 412.00 Month 294.00
1 Year 0.48 3 Year 0.40
Over 1 Month
-25.83% down
Over 1 Year
174.03% down
Over 3 Months
-16.57% down
Over 3 Years
51.82% down
Over 6 Months
56.87% down
Over 5 Years
16.29% down

PHAARMASIA LTD. Corporate Actions

Top Gainers

Top Losers

PHAARMASIA LTD. Share Price

Incorporated in 1981, Phaarmasia Limited is a manufacturing unit dedicated in manufacturing facility of Hormonal (Oral contraceptive tablets) and Combipack with Iron Tablet. M/s Phaarmasia Limited Unit-II was established in 1993-94.

The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum.

During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.

During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMP
certified and ISO 9001-certified manufacturing facility.

Parent organization Indian Private
NSE symbol [-]
Founded 1981
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Phaarmasia Ltd?

Answer Field

Phaarmasia Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 81.50 as on May 26 2026 02:25 PM.

What is the Market Cap of Phaarmasia Ltd Share?

Answer Field

The market cap of Phaarmasia Ltd for NSE ₹ 0.00 & for BSE ₹ 55.70 as on May 26 2026 02:25 PM.

What is the 52 Week High and Low of Phaarmasia Ltd?

Answer Field

The 52 Week High and Low of Phaarmasia Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 131.75 and ₹ 26.00.

What is 1 year return for Phaarmasia Ltd?

Answer Field

The 1 year returns on the stock has been 175.34%.

What is the P/E Ratio of Phaarmasia Ltd Share?

Answer Field

As on May 26 2026 02:25 PM the price-to-earnings (PE) ratio for Phaarmasia Ltd share is 3.11.

What is the PB ratio of Phaarmasia Ltd Share?

Answer Field

As on May 26 2026 02:25 PM, the price-to-book (PB) ratio for Phaarmasia Ltd share is 9.52.

How to Buy Phaarmasia Ltd Share?

Answer Field

You can trade in Phaarmasia Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Phaarmasia Ltd Share on Bajaj Broking App?

Answer Field

To buy Phaarmasia Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Phaarmasia Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|